Skip to main content
Jonathan Schoenfeld, MD, Radiation Oncology, Boston, MA, Dana-Farber Cancer Institute

JonathanDanielSchoenfeldMDMPH

Radiation Oncology Boston, MA

Attending Radiation Oncologist, Director of Head and Neck Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center; Associate Professor in Radiation Oncology Harvard Medical School

Dr. Schoenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schoenfeld's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009 - 2013
  • Harvard Medical School
    Harvard Medical SchoolClass of 2008, cum laude
  • University of Cambridge
    University of CambridgeMPhil, 2002 - 2003
  • Harvard School of Public Health
    Harvard School of Public HealthMPH
  • Yale University
    Yale UniversityBS, summa cum laude

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2010 - 2025
  • FL State Medical License
    FL State Medical License 2020 - 2022
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Gates Cambridge Scholar Gates Cambridge Trust

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Study Identifies T-cell Populations That Predict Response to Immunotherapy
    Study Identifies T-cell Populations That Predict Response to ImmunotherapyJuly 12th, 2022
  • Study Identifies T-cell Populations That Predict Response to Immunotherapy
    Study Identifies T-cell Populations That Predict Response to ImmunotherapyJuly 11th, 2022
  • ECOG-ACRIN Research Highlights at ASCO 2022
    ECOG-ACRIN Research Highlights at ASCO 2022May 27th, 2022
  • Join now to see all

Hospital Affiliations